Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-kappaB nuclear translocation.

Guitart A, Riezu-Boj JI, Elizalde E, Larrea E, Berasain C, Aldabe R, Civeira MP, Prieto J.

J Gen Virol. 2005 Nov;86(Pt 11):3065-74.

2.

Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Zhao X, Tang ZY, Klumpp B, Wolff-Vorbeck G, Barth H, Levy S, von Weizsäcker F, Blum HE, Baumert TF.

J Clin Invest. 2002 Jan;109(2):221-32.

3.

[Infection of tupaia hepatocytes with hepatitis C virus in vitro].

Zhao XP, Tian ZF, Chen YC, Yang C, Tian DY, Yang DL, Hao LJ.

Zhonghua Gan Zang Bing Za Zhi. 2005 Nov;13(11):805-7. Chinese.

PMID:
16313720
4.

Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, Liu C.

Gastroenterology. 2007 Nov;133(5):1649-59. Epub 2007 Sep 16.

PMID:
17983809
5.

Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro.

Kato N, Sugiyama K, Namba K, Dansako H, Nakamura T, Takami M, Naka K, Nozaki A, Shimotohno K.

Biochem Biophys Res Commun. 2003 Jul 4;306(3):756-66.

PMID:
12810084
6.
7.

Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.

Brownell J, Bruckner J, Wagoner J, Thomas E, Loo YM, Gale M Jr, Liang TJ, Polyak SJ.

J Virol. 2014 Feb;88(3):1582-90. doi: 10.1128/JVI.02007-13. Epub 2013 Nov 20.

8.

Host cell responses induced by hepatitis C virus binding.

Fang X, Zeisel MB, Wilpert J, Gissler B, Thimme R, Kreutz C, Maiwald T, Timmer J, Kern WV, Donauer J, Geyer M, Walz G, Depla E, von Weizsäcker F, Blum HE, Baumert TF.

Hepatology. 2006 Jun;43(6):1326-36.

9.

Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.

Raymond VA, Selliah S, Ethier C, Houle R, Jouan L, Maniere T, Lamarre D, Willems B, Bilodeau M.

Liver Int. 2009 Jul;29(6):942-9. doi: 10.1111/j.1478-3231.2009.01996.x. Epub 2009 Mar 3.

PMID:
19302183
10.

Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.

Tong Y, Zhu Y, Xia X, Liu Y, Feng Y, Hua X, Chen Z, Ding H, Gao L, Wang Y, Feitelson MA, Zhao P, Qi ZT.

J Virol. 2011 Mar;85(6):2793-802. doi: 10.1128/JVI.01818-10. Epub 2010 Dec 22.

11.

3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.

Aly HH, Shimotohno K, Hijikata M.

Biochem Biophys Res Commun. 2009 Feb 6;379(2):330-4. doi: 10.1016/j.bbrc.2008.12.054. Epub 2008 Dec 25.

PMID:
19103167
12.

Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.

Baumert TF, Yang C, Schürmann P, Köck J, Ziegler C, Grüllich C, Nassal M, Liang TJ, Blum HE, von Weizsäcker F.

Hepatology. 2005 Feb;41(2):247-56.

PMID:
15660384
13.

Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.

Aly HH, Watashi K, Hijikata M, Kaneko H, Takada Y, Egawa H, Uemoto S, Shimotohno K.

J Hepatol. 2007 Jan;46(1):26-36. Epub 2006 Oct 30.

PMID:
17112629
14.

Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro.

Valli MB, Crema A, Lanzilli G, Serafino A, Bertolini L, Ravagnan G, Ponzetto A, Menzo S, Clementi M, Carloni G.

J Med Virol. 2007 Oct;79(10):1491-9.

PMID:
17705190
15.

Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV).

Aly HH, Oshiumi H, Shime H, Matsumoto M, Wakita T, Shimotohno K, Seya T.

PLoS One. 2011;6(6):e21284. doi: 10.1371/journal.pone.0021284. Epub 2011 Jun 22.

16.

Alcohol potentiates hepatitis C virus replicon expression.

Zhang T, Li Y, Lai JP, Douglas SD, Metzger DS, O'Brien CP, Ho WZ.

Hepatology. 2003 Jul;38(1):57-65.

PMID:
12829987
17.

Primary human hepatocytes in spheroid formation to study hepatitis C infection.

Chong TW, Smith RL, Hughes MG, Camden J, Rudy CK, Evans HL, Sawyer RG, Pruett TL.

J Surg Res. 2006 Jan;130(1):52-7. Epub 2005 Sep 8.

PMID:
16154152
19.

[The effects of hepatitis C virus core protein on biological behaviors of human hepatocytes].

Li B, Feng DY, Cheng RX, He QQ, Hu ZL, Zheng H, Wen JF.

Zhonghua Yi Xue Za Zhi. 2005 May 18;85(18):1243-8. Chinese.

PMID:
16029608
20.

Hepatitis C virus clearance: the enigma of failure despite an impeccable survival strategy.

Isaguliants MG.

Curr Pharm Biotechnol. 2003 Jun;4(3):169-83. Review.

PMID:
12769761

Supplemental Content

Support Center